Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus

James B. Lefkowith, Mary Kiehl, Joel Rubenstein, Richard Di Valerio, Keith Bernstein, Leslie Kahl, Robert L. Rubin, Mark Gourley

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

We used an ELISA employing extracts of human glomerular basement membrane (GBM) to detect, characterize, and evaluate the clinical significance of glomerular-binding IgG in patients with SLE nephritis. Most patients with SLE nephritis exhibited GBM-binding IgG, although many patients with active nonrenal SLE or symptomatic, drug-induced lupus had similar reactivity, albeit at lower levels. IgG binding to GBM in SLE nephritis patients was decreased by DNase pretreatment of GBM, restored after DNase with nuclear antigens (most notably with nucleosomes), inhibited by exogenous nuclear antigens (particularly nucleosomes), but unaffected by exposure of serum to DNase/high ionic strength. The characteristics of IgG binding to GBM largely paralleled the patients' underlying autoimmune response, which was dominated either by antibodies to DNA/nucleosomes or to nucleosomes alone. Binding of lupus sera to nonrenal extracellular matrix (even with nucleosomes) was not equivalent to GBM. Collagenase pretreatment of GBM variably decreased IgG binding, depending on the level and type of binding. SLE nephritis patients with high levels of GBM-binding IgG exhibited more severe disease clinically, but the same renal histopathology, as patients with lower levels. The level of GBM-binding IgG at presentation did not predict the therapeutic response, but decreased in responders to therapy. In sum, glomerular-binding IgG in lupus nephritis binds to epitopes on chromatin, which adheres to GBM in part via collagen. These autoantibodies appear necessary, but not sufficient, for the development of nephritis, and correlate with clinical rather than histopathologic parameters of disease activity.

Original languageEnglish (US)
Pages (from-to)1373-1380
Number of pages8
JournalJournal of Clinical Investigation
Volume98
Issue number6
StatePublished - Sep 15 1996
Externally publishedYes

Fingerprint

Glomerular Basement Membrane
Systemic Lupus Erythematosus
Immunoglobulin G
Nucleosomes
Antibodies
Nephritis
Deoxyribonucleases
Nuclear Antigens
Lupus Nephritis
Collagenases
Serum
Autoimmunity
Autoantibodies
Osmolar Concentration
Chromatin
Extracellular Matrix
Epitopes
Collagen
Enzyme-Linked Immunosorbent Assay
Kidney

Keywords

  • autoantibodies
  • glomerular basement membrane
  • lupus nephritis
  • nucleosomes
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lefkowith, J. B., Kiehl, M., Rubenstein, J., Di Valerio, R., Bernstein, K., Kahl, L., ... Gourley, M. (1996). Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. Journal of Clinical Investigation, 98(6), 1373-1380.

Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. / Lefkowith, James B.; Kiehl, Mary; Rubenstein, Joel; Di Valerio, Richard; Bernstein, Keith; Kahl, Leslie; Rubin, Robert L.; Gourley, Mark.

In: Journal of Clinical Investigation, Vol. 98, No. 6, 15.09.1996, p. 1373-1380.

Research output: Contribution to journalArticle

Lefkowith, JB, Kiehl, M, Rubenstein, J, Di Valerio, R, Bernstein, K, Kahl, L, Rubin, RL & Gourley, M 1996, 'Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus', Journal of Clinical Investigation, vol. 98, no. 6, pp. 1373-1380.
Lefkowith JB, Kiehl M, Rubenstein J, Di Valerio R, Bernstein K, Kahl L et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. Journal of Clinical Investigation. 1996 Sep 15;98(6):1373-1380.
Lefkowith, James B. ; Kiehl, Mary ; Rubenstein, Joel ; Di Valerio, Richard ; Bernstein, Keith ; Kahl, Leslie ; Rubin, Robert L. ; Gourley, Mark. / Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. In: Journal of Clinical Investigation. 1996 ; Vol. 98, No. 6. pp. 1373-1380.
@article{3894f74d466e49558dc9fab9be0df6d3,
title = "Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus",
abstract = "We used an ELISA employing extracts of human glomerular basement membrane (GBM) to detect, characterize, and evaluate the clinical significance of glomerular-binding IgG in patients with SLE nephritis. Most patients with SLE nephritis exhibited GBM-binding IgG, although many patients with active nonrenal SLE or symptomatic, drug-induced lupus had similar reactivity, albeit at lower levels. IgG binding to GBM in SLE nephritis patients was decreased by DNase pretreatment of GBM, restored after DNase with nuclear antigens (most notably with nucleosomes), inhibited by exogenous nuclear antigens (particularly nucleosomes), but unaffected by exposure of serum to DNase/high ionic strength. The characteristics of IgG binding to GBM largely paralleled the patients' underlying autoimmune response, which was dominated either by antibodies to DNA/nucleosomes or to nucleosomes alone. Binding of lupus sera to nonrenal extracellular matrix (even with nucleosomes) was not equivalent to GBM. Collagenase pretreatment of GBM variably decreased IgG binding, depending on the level and type of binding. SLE nephritis patients with high levels of GBM-binding IgG exhibited more severe disease clinically, but the same renal histopathology, as patients with lower levels. The level of GBM-binding IgG at presentation did not predict the therapeutic response, but decreased in responders to therapy. In sum, glomerular-binding IgG in lupus nephritis binds to epitopes on chromatin, which adheres to GBM in part via collagen. These autoantibodies appear necessary, but not sufficient, for the development of nephritis, and correlate with clinical rather than histopathologic parameters of disease activity.",
keywords = "autoantibodies, glomerular basement membrane, lupus nephritis, nucleosomes, systemic lupus erythematosus",
author = "Lefkowith, {James B.} and Mary Kiehl and Joel Rubenstein and {Di Valerio}, Richard and Keith Bernstein and Leslie Kahl and Rubin, {Robert L.} and Mark Gourley",
year = "1996",
month = "9",
day = "15",
language = "English (US)",
volume = "98",
pages = "1373--1380",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus

AU - Lefkowith, James B.

AU - Kiehl, Mary

AU - Rubenstein, Joel

AU - Di Valerio, Richard

AU - Bernstein, Keith

AU - Kahl, Leslie

AU - Rubin, Robert L.

AU - Gourley, Mark

PY - 1996/9/15

Y1 - 1996/9/15

N2 - We used an ELISA employing extracts of human glomerular basement membrane (GBM) to detect, characterize, and evaluate the clinical significance of glomerular-binding IgG in patients with SLE nephritis. Most patients with SLE nephritis exhibited GBM-binding IgG, although many patients with active nonrenal SLE or symptomatic, drug-induced lupus had similar reactivity, albeit at lower levels. IgG binding to GBM in SLE nephritis patients was decreased by DNase pretreatment of GBM, restored after DNase with nuclear antigens (most notably with nucleosomes), inhibited by exogenous nuclear antigens (particularly nucleosomes), but unaffected by exposure of serum to DNase/high ionic strength. The characteristics of IgG binding to GBM largely paralleled the patients' underlying autoimmune response, which was dominated either by antibodies to DNA/nucleosomes or to nucleosomes alone. Binding of lupus sera to nonrenal extracellular matrix (even with nucleosomes) was not equivalent to GBM. Collagenase pretreatment of GBM variably decreased IgG binding, depending on the level and type of binding. SLE nephritis patients with high levels of GBM-binding IgG exhibited more severe disease clinically, but the same renal histopathology, as patients with lower levels. The level of GBM-binding IgG at presentation did not predict the therapeutic response, but decreased in responders to therapy. In sum, glomerular-binding IgG in lupus nephritis binds to epitopes on chromatin, which adheres to GBM in part via collagen. These autoantibodies appear necessary, but not sufficient, for the development of nephritis, and correlate with clinical rather than histopathologic parameters of disease activity.

AB - We used an ELISA employing extracts of human glomerular basement membrane (GBM) to detect, characterize, and evaluate the clinical significance of glomerular-binding IgG in patients with SLE nephritis. Most patients with SLE nephritis exhibited GBM-binding IgG, although many patients with active nonrenal SLE or symptomatic, drug-induced lupus had similar reactivity, albeit at lower levels. IgG binding to GBM in SLE nephritis patients was decreased by DNase pretreatment of GBM, restored after DNase with nuclear antigens (most notably with nucleosomes), inhibited by exogenous nuclear antigens (particularly nucleosomes), but unaffected by exposure of serum to DNase/high ionic strength. The characteristics of IgG binding to GBM largely paralleled the patients' underlying autoimmune response, which was dominated either by antibodies to DNA/nucleosomes or to nucleosomes alone. Binding of lupus sera to nonrenal extracellular matrix (even with nucleosomes) was not equivalent to GBM. Collagenase pretreatment of GBM variably decreased IgG binding, depending on the level and type of binding. SLE nephritis patients with high levels of GBM-binding IgG exhibited more severe disease clinically, but the same renal histopathology, as patients with lower levels. The level of GBM-binding IgG at presentation did not predict the therapeutic response, but decreased in responders to therapy. In sum, glomerular-binding IgG in lupus nephritis binds to epitopes on chromatin, which adheres to GBM in part via collagen. These autoantibodies appear necessary, but not sufficient, for the development of nephritis, and correlate with clinical rather than histopathologic parameters of disease activity.

KW - autoantibodies

KW - glomerular basement membrane

KW - lupus nephritis

KW - nucleosomes

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=0029764038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029764038&partnerID=8YFLogxK

M3 - Article

C2 - 8823302

AN - SCOPUS:0029764038

VL - 98

SP - 1373

EP - 1380

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -